• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women.CYP19(芳香化酶)基因中的简单串联重复序列(TTTA)n多态性与尼日利亚女性乳腺癌风险
J Carcinog. 2006 May 9;5:12. doi: 10.1186/1477-3163-5-12.
2
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.细胞色素P450 19(CYP19)基因TTTA重复序列多态性与绝经前Ⅰ-Ⅱ期及可手术Ⅲ期乳腺癌的预后相关。
Oncologist. 2008 Jul;13(7):751-60. doi: 10.1634/theoncologist.2007-0246. Epub 2008 Jul 9.
3
Distinct prevalence of the CYP19 Delta3(TTTA)(7) allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals.CYP19 Delta3(TTTA)(7)等位基因在绝经前与绝经后乳腺癌患者中的患病率不同,但在对照个体中无此差异。
Eur J Cancer. 2002 Sep;38(14):1911-6. doi: 10.1016/s0959-8049(02)00149-1.
4
Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.尼日利亚女性中瘦素受体Gln223Arg多态性与乳腺癌风险:一项病例对照研究。
BMC Cancer. 2008 Nov 18;8:338. doi: 10.1186/1471-2407-8-338.
5
A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.细胞色素P450 19(CYP19)基因中的四核苷酸重复多态性与乳腺癌风险
Int J Cancer. 2000 Jul 15;87(2):204-10.
6
Anthropometry and breast cancer risk in Nigerian women.尼日利亚女性的人体测量学与乳腺癌风险
Breast J. 2006 Sep-Oct;12(5):462-6. doi: 10.1111/j.1075-122X.2006.00304.x.
7
Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population.细胞色素P450 19(CYP19)基因内含子4 [TTTA]n重复序列的基因多态性与日本人群家族性前列腺癌风险的关联
Anticancer Res. 2003 Nov-Dec;23(6D):4941-6.
8
Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women.健康女性和乳腺癌确诊女性的端粒长度与CYP19 TTTA重复多态性之间的关联。
Breast Cancer (Dove Med Press). 2017 Jan 13;9:21-27. doi: 10.2147/BCTT.S125431. eCollection 2017.
9
Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.雌激素代谢基因多态性与乳腺癌风险:一项多基因研究。
Chin Med J (Engl). 2005 Sep 20;118(18):1507-16.
10
The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.韩国女性中CYP19基因多态性与乳腺癌风险之间的关联。
Oncol Rep. 2009 Sep;22(3):487-92.

引用本文的文献

1
Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women.健康女性和乳腺癌确诊女性的端粒长度与CYP19 TTTA重复多态性之间的关联。
Breast Cancer (Dove Med Press). 2017 Jan 13;9:21-27. doi: 10.2147/BCTT.S125431. eCollection 2017.
2
Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.乳腺癌预防试验中基因组多态性与癌症风险相互作用的新型通路分析。
Int J Mol Epidemiol Genet. 2010;1(4):332-49. Epub 2010 Sep 5.
3
An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese men.芳香化酶多态性调节肥胖男性体重与雌二醇水平之间的关系。
Fertil Steril. 2010 Oct;94(5):1734-8. doi: 10.1016/j.fertnstert.2009.10.037. Epub 2009 Dec 11.
4
Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study.细胞色素 P450 1B1 Val432Leu 多态性与尼日利亚妇女乳腺癌风险的病例对照研究。
Infect Agent Cancer. 2009 Feb 10;4 Suppl 1(Suppl 1):S12. doi: 10.1186/1750-9378-4-S1-S12.
5
Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.中国上海女性中CYP19A1基因变异与乳腺癌及乳腺纤维囊性病变风险
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3457-66. doi: 10.1158/1055-9965.EPI-08-0517.
6
Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.尼日利亚女性中瘦素受体Gln223Arg多态性与乳腺癌风险:一项病例对照研究。
BMC Cancer. 2008 Nov 18;8:338. doi: 10.1186/1471-2407-8-338.
7
What do we know about the mechanisms of aromatase inhibitor resistance?我们对芳香化酶抑制剂耐药的机制了解多少?
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):232-40. doi: 10.1016/j.jsbmb.2006.09.012. Epub 2006 Oct 19.

本文引用的文献

1
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.CYP19与乳腺癌风险的综合单倍型分析:多民族队列研究
Hum Mol Genet. 2003 Oct 15;12(20):2679-92. doi: 10.1093/hmg/ddg294. Epub 2003 Aug 27.
2
A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.细胞色素P450 19(CYP19)基因中的四核苷酸重复多态性与乳腺癌风险
Int J Cancer. 2000 Jul 15;87(2):204-10.
3
Aromatase and breast cancer susceptibility.芳香化酶与乳腺癌易感性。
Endocr Relat Cancer. 1999 Jun;6(2):165-73. doi: 10.1677/erc.0.0060165.
4
Genetic variants of CYP19 (aromatase) and breast cancer risk.细胞色素P450 19(芳香化酶)的基因变异与乳腺癌风险
Oncogene. 2000 Mar 2;19(10):1329-33. doi: 10.1038/sj.onc.1203425.
5
Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.人类芳香化酶细胞色素P450基因(CYP19)多态性与乳腺癌风险
Carcinogenesis. 2000 Feb;21(2):189-93. doi: 10.1093/carcin/21.2.189.
6
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 1999 Jan-Feb;49(1):33-64, 1. doi: 10.3322/canjclin.49.1.33.
7
Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk.人类芳香化酶基因(Cyp19)的体质性遗传变异与乳腺癌风险。
Br J Cancer. 1999 Feb;79(3-4):456-63. doi: 10.1038/sj.bjc.6690071.
8
A rare CYP19 (aromatase) variant may increase the risk of breast cancer.一种罕见的CYP19(芳香化酶)变体可能会增加患乳腺癌的风险。
Pharmacogenetics. 1998 Feb;8(1):43-8. doi: 10.1097/00008571-199802000-00006.
9
Aromatase inhibitors as potential cancer chemopreventives.芳香化酶抑制剂作为潜在的癌症化学预防剂。
Cancer Epidemiol Biomarkers Prev. 1998 Jan;7(1):65-78.
10
Dual effects of weight and weight gain on breast cancer risk.体重及体重增加对乳腺癌风险的双重影响。
JAMA. 1997 Nov 5;278(17):1407-11.

CYP19(芳香化酶)基因中的简单串联重复序列(TTTA)n多态性与尼日利亚女性乳腺癌风险

Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women.

作者信息

Okobia Michael N, Bunker Clareann H, Zmuda Joseph M, Ezeome Emmanuel R, Anyanwu Stanley N C, Uche Emmanuel E O, Ojukwu Joseph, Kuller Lewis H, Ferrell Robert E

机构信息

Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.

出版信息

J Carcinog. 2006 May 9;5:12. doi: 10.1186/1477-3163-5-12.

DOI:10.1186/1477-3163-5-12
PMID:16684355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1475832/
Abstract

BACKGROUND

Breast cancer is the most common cancer and the leading cause of cancer related deaths in women worldwide. The incidence of the disease is increasing globally and this increase is occurring at a faster rate in population groups that hirtherto enjoyed low incidence. This study was designed to evaluate the role of a simple tandem repeat polymorphism (STRP) in the aromatase (CYP19) gene in breast cancer susceptibility in Nigerian women, a population of indigenous sub-Saharan African ancestry.

METHODS

A case-control study recruiting 250 women with breast cancer and 250 women without the disease from four University Teaching Hospitals in Southern Nigeria was carried out between September 2002 and April 2004. Participants were recruited from the surgical outpatient clinics and surgical wards of the Nigerian institutions. A polymerase chain reaction (PCR)-based assay was employed for genotyping and product sizes were detected with an ABI 3730 DNA Analyzer.

RESULTS

Conditional logistic regression analysis revealed that harboring the putative high risk genotypes conferred a 29% increased risk of breast cancer when all women in the study were considered (Odds ratio [OR] = 1.29, 95% confidence interval [CI] 0.83-2.00), although this association was not statistically significant. Subgroup analysis based on menopausal status showed similar results among premenopausal women (OR = 1.35, 95% CI 0.76-2.41 and postmenopausal women (OR = 1.27, 95% CI 0.64-2.49). The data also demonstrated marked differences in the distribution of (TTTA)n repeats in Nigerian women compared with other populations.

CONCLUSION

This study has shown that harboring 10 or more repeats of the microsatellite (TTTA)n repeats of the CYY19 gene is associated with a modest increased risk of breast cancer in Nigerian women.

摘要

背景

乳腺癌是全球女性中最常见的癌症,也是癌症相关死亡的主要原因。该疾病的发病率在全球范围内呈上升趋势,且在以往发病率较低的人群中上升速度更快。本研究旨在评估芳香化酶(CYP19)基因中的一种简单串联重复多态性(STRP)在尼日利亚女性乳腺癌易感性中的作用,尼日利亚女性为撒哈拉以南非洲本土血统人群。

方法

2002年9月至2004年4月间,在尼日利亚南部的四家大学教学医院开展了一项病例对照研究,招募了250名乳腺癌女性患者和250名无该疾病的女性。参与者从尼日利亚各机构的外科门诊和外科病房招募。采用基于聚合酶链反应(PCR)的检测方法进行基因分型,并使用ABI 3730 DNA分析仪检测产物大小。

结果

条件逻辑回归分析显示,当考虑研究中的所有女性时,携带假定的高风险基因型会使患乳腺癌的风险增加29%(优势比[OR]=1.29,95%置信区间[CI]0.83 - 2.00),尽管这种关联在统计学上并不显著。基于绝经状态的亚组分析在绝经前女性(OR = 1.35,95% CI 0.76 - 2.41)和绝经后女性(OR = 1.27,95% CI 0.64 - 2.49)中显示出相似结果。数据还表明,与其他人群相比,尼日利亚女性中(TTTA)n重复序列的分布存在显著差异。

结论

本研究表明,CYY19基因的微卫星(TTTA)n重复序列有10次或更多次重复与尼日利亚女性患乳腺癌的风险适度增加相关。